WHO Model Prescribing Information: Drugs Used in Skin Diseases
(1997; 132 pages) [French] [Spanish] Voir le document au format PDF
Table des matières
Afficher le documentPreface
Afficher le documentIntroduction
Ouvrir ce répertoire et afficher son contenuParasitic infections
Ouvrir ce répertoire et afficher son contenuInsect and arachnid bites and stings
Ouvrir ce répertoire et afficher son contenuSuperficial fungal infections
Ouvrir ce répertoire et afficher son contenuSubcutaneous fungal infections
Ouvrir ce répertoire et afficher son contenuBacterial infections
Fermer ce répertoireViral infections
Afficher le documentWarts
Afficher le documentHerpes simplex
Afficher le documentZoster and varicella
Afficher le documentMolluscum contagiosum
Ouvrir ce répertoire et afficher son contenuEczematous diseases
Ouvrir ce répertoire et afficher son contenuScaling diseases
Ouvrir ce répertoire et afficher son contenuPapulosquamous diseases
Afficher le documentCutaneous reactions to drugs
Ouvrir ce répertoire et afficher son contenuPigmentary disorders
Ouvrir ce répertoire et afficher son contenuPremalignant lesions and malignant tumours
Ouvrir ce répertoire et afficher son contenuPhotodermatoses
Ouvrir ce répertoire et afficher son contenuBullous dermatoses
Afficher le documentAlopecia areata
Afficher le documentUrticaria
Ouvrir ce répertoire et afficher son contenuConditions common in children
Afficher le documentAcne vulgaris
Afficher le documentPruritus
Afficher le documentTropical ulcers
Ouvrir ce répertoire et afficher son contenuAntimicrobial drugs
Ouvrir ce répertoire et afficher son contenuAntifugal drugs
Ouvrir ce répertoire et afficher son contenuAntiseptic agents
Ouvrir ce répertoire et afficher son contenuKeratoplastic and keratolytic agents
Ouvrir ce répertoire et afficher son contenuScabicides and pediculicides
Ouvrir ce répertoire et afficher son contenuAnti-inflammatory and antipruritic drugs1
Ouvrir ce répertoire et afficher son contenuAntiallergics and drugs used in anaphylaxis
Ouvrir ce répertoire et afficher son contenuUltraviolet radiation-blocking agents (sunscreens)
Ouvrir ce répertoire et afficher son contenuMiscellaneous drugs
Ouvrir ce répertoire et afficher son contenuAnnex
Afficher le documentSelected WHO Publications of Related Interest
Afficher le documentBack cover
 

Warts

Warts (verrucae) are caused by the human papillomavirus and may regress spontaneously at any time within months or years of their first appearance. However, particularly in immunosuppressed patients, they may become widespread and difficult to cure.

Treatment

Many common, plane and plantar warts can be left untreated, but painful or unsightly lesions generally respond to application of paints or lotions containing salicylic acid. Where available, liquid nitrogen applied with a cotton-tipped swab or a spray is highly effective. However, caution is required, since freezing can cause temporary or permanent depigmentation of the skin.

Genital warts (condylomata acuminata), which are transmitted by sexual contact, should always be treated, even though they frequently recur, since they may increase the risk of cervical cancer. Podophyllum resin, 10-25% in compound tincture of benzoin, should be applied carefully and sparingly to external genital, perianal and vaginal warts at weekly intervals up to a maximum of four applications; normal tissue should be avoided. Resin applied to the vaginal mucosa should be allowed to dry before it comes into contact with normal epithelium. Where it is available, podophyllotoxin is a less toxic alternative that can be applied by the patient. Trichloroacetic acid may be applied directly to the wart, but it is less effective and the treated area should be powdered with talc or sodium bicarbonate to remove excess acid.

External applications of podophyllum resin and podophyllotoxin should be removed by washing after 1-4 hours. Podophyllum resin is readily absorbed, locally destructive and teratogenic. Neither podophyllum resin nor podophyllotoxin should be applied to large skin surfaces, nor should they be used during pregnancy.

Surgical removal, electrocautery, cryosurgery and laser treatment may be used for genital warts when topical applications have failed or are contraindicated. Topical application of fluorouracil, 5% ointment, and intralesional or systemic administration of an interferon are also reported to be of value in resistant cases, but these treatments are expensive.

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 24 avril 2012